#COVID-19

J&J adds to COVID-19 vaccine armoury with 66% efficacy in global trial

In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from 72% in the United States, to 66% in Latin America and just 57% in South Africa, from where a worrying variant has spread.
By Reuters

New York prosecutor says state undercounted nursing home COVID deaths by up to 50%

New York state's health department may have undercounted the COVID-19 death toll in state nursing home residents by as much as 50%, according to a report released by the state attorney general's office on Thursday.
By Reuters

More than 150 National Guard in Washington for inauguration test positive for coronavirus

Between 150 and 200 National Guard deployed to Washington, D.C., to provide security for President Joe Biden's inauguration have tested positive for the coronavirus, a U.S. official said on Friday.
By Reuters

top Business stories, straight to your inbox.

U.S. Senate wrangles over $2,000 stimulus checks, defense veto as deadline looms

The U.S. Senate will grapple on Tuesday with whether to increase payments to Americans reeling from the COVID-19 pandemic and override President Donald Trump's veto of a $740 billion defense bill, two measures set to lapse if lawmakers fail to act before a new Congress takes office on Sunday.
By Reuters

Wall Street climbs to record as fiscal aid bill signed

-U.S. stocks rallied on Monday, with each of Wall Street's main indexes closing at record levels as President Donald Trump's signing of a long-awaited $2.3 trillion pandemic aid bill increased optimism for an economic recovery.
By Reuters

U.S. appeals court blocks NY governor's limits on religious gatherings

The federal appeals court in Manhattan on Monday blocked New York state restrictions on the size of religious gatherings put in place to combat the spread of the coronavirus.
By Reuters

After Trump backs down on stimulus bill, Democrats aim for higher relief checks

Democrats in the U.S. Congress on Monday will try to push through expanded $2,000 pandemic relief payments for Americans after President Donald Trump backed down from a fight with lawmakers that could have shut down the federal government.
By Reuters

Coronavirus aid at risk as U.S. lawmakers block Trump's changes

U.S. lawmakers on Thursday blocked attempts to alter a $2.3 trillion coronavirus aid and government spending package, rejecting President Donald Trump's demand for extensive changes and leaving benefits for millions of Americans at risk.
By Reuters

U.S. faces risk of government shutdown as Trump balks at COVID-19 relief deal

Americans on Wednesday faced the prospect of a government shutdown during a pandemic as outgoing President Donald Trump, angry at his fellow Republicans in Congress, demanded dramatic changes to a $2.3 trillion government funding and coronavirus aid package.
By Reuters

BioNTech-Pfizer vaccine heads to EU as effectiveness against new strain tested

BioNTech is testing the effectiveness of the COVID-19 vaccine it developed with Pfizer against a highly infectious new strain of the coronavirus as it prepares to send 12.5 mln doses to EU countries by the end of year.
By Reuters
1 2 3 4